FDA Inspection 685618 — Merz North America, Inc.
The FDA completed an inspection of Merz North America, Inc. on Sep 29, 2010 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 29, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Raleigh, NC (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)